Molina, Rosana S.
Rix, Gordon
Mengiste, Amanuella A.
Álvarez, Beatriz https://orcid.org/0000-0002-9613-5473
Seo, Daeje
Chen, Haiqi
Hurtado, Juan E.
Zhang, Qiong https://orcid.org/0000-0001-6029-4651
García-García, Jorge Donato
Heins, Zachary J. https://orcid.org/0000-0002-4058-0017
Almhjell, Patrick J. https://orcid.org/0000-0003-0977-841X
Arnold, Frances H. https://orcid.org/0000-0002-4027-364X
Khalil, Ahmad S. https://orcid.org/0000-0002-8214-0546
Hanson, Andrew D.
Dueber, John E.
Schaffer, David V. https://orcid.org/0000-0002-9625-0121
Chen, Fei
Kim, Seokhee https://orcid.org/0000-0003-0806-583X
Fernández, Luis Ángel
Shoulders, Matthew D. https://orcid.org/0000-0002-6511-3431
Liu, Chang C.
Article History
Accepted: 28 March 2022
First Online: 19 May 2022
Competing interests
: C.C.L. is a co-founder of K2 Biotechnologies, which applies continuous evolution to antibody engineering. All other authors declare no competing interests.